Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: QYResearch | PRODUCT CODE: 1119634

Cover Image

PUBLISHER: QYResearch | PRODUCT CODE: 1119634

Global Epilepsy Drugs Market Insights, Forecast to 2028

PUBLISHED:
PAGES: 117 Pages
DELIVERY TIME: 2-3 business days
SELECT AN OPTION
PDF (Single User License)
USD 4900
PDF (Multi User License)
USD 7350
PDF (Enterprise User License)
USD 9800

Add to Cart

This research report focuses on the Epilepsy Drugs Market. It analyzes market size, trends and demand forecasts, as well as growth factors and challenges. The report provides market data breakdowns by type, application, company, and region, in addition to competitive landscape and key company profiles.

TABLE OF CONTENTS

1 Report Business Overview

  • 1.1 Study Scope
  • 1.2 Market Analysis by Type
    • 1.2.1 Global Epilepsy Drugs Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
    • 1.2.2 First Generation
    • 1.2.3 Second Generation
  • 1.3 Market by Application
    • 1.3.1 Global Epilepsy Drugs Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
    • 1.3.2 Hospital Pharmacies
    • 1.3.3 Retail Pharmacies
    • 1.3.4 Online Pharmacies
  • 1.4 Study Objectives
  • 1.5 Years Considered

2 Global Growth Trends

  • 2.1 Global Epilepsy Drugs Market Perspective (2017-2028)
  • 2.2 Epilepsy Drugs Growth Trends by Region
    • 2.2.1 Epilepsy Drugs Market Size by Region: 2017 VS 2021 VS 2028
    • 2.2.2 Epilepsy Drugs Historic Market Size by Region (2017-2022)
    • 2.2.3 Epilepsy Drugs Forecasted Market Size by Region (2023-2028)
  • 2.3 Epilepsy Drugs Market Dynamics
    • 2.3.1 Epilepsy Drugs Industry Trends
    • 2.3.2 Epilepsy Drugs Market Drivers
    • 2.3.3 Epilepsy Drugs Market Challenges
    • 2.3.4 Epilepsy Drugs Market Restraints

3 Competition Landscape by Key Players

  • 3.1 Global Top Epilepsy Drugs Players by Revenue
    • 3.1.1 Global Top Epilepsy Drugs Players by Revenue (2017-2022)
    • 3.1.2 Global Epilepsy Drugs Revenue Market Share by Players (2017-2022)
  • 3.2 Global Epilepsy Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
  • 3.3 Players Covered: Ranking by Epilepsy Drugs Revenue
  • 3.4 Global Epilepsy Drugs Market Concentration Ratio
    • 3.4.1 Global Epilepsy Drugs Market Concentration Ratio (CR5 and HHI)
    • 3.4.2 Global Top 10 and Top 5 Companies by Epilepsy Drugs Revenue in 2021
  • 3.5 Epilepsy Drugs Key Players Head office and Area Served
  • 3.6 Key Players Epilepsy Drugs Product Solution and Service
  • 3.7 Date of Enter into Epilepsy Drugs Market
  • 3.8 Mergers & Acquisitions, Expansion Plans

4 Epilepsy Drugs Breakdown Data by Type

  • 4.1 Global Epilepsy Drugs Historic Market Size by Type (2017-2022)
  • 4.2 Global Epilepsy Drugs Forecasted Market Size by Type (2023-2028)

5 Epilepsy Drugs Breakdown Data by Application

  • 5.1 Global Epilepsy Drugs Historic Market Size by Application (2017-2022)
  • 5.2 Global Epilepsy Drugs Forecasted Market Size by Application (2023-2028)

6 North America

  • 6.1 North America Epilepsy Drugs Market Size (2017-2028)
  • 6.2 North America Epilepsy Drugs Market Size by Type
    • 6.2.1 North America Epilepsy Drugs Market Size by Type (2017-2022)
    • 6.2.2 North America Epilepsy Drugs Market Size by Type (2023-2028)
    • 6.2.3 North America Epilepsy Drugs Market Share by Type (2017-2028)
  • 6.3 North America Epilepsy Drugs Market Size by Application
    • 6.3.1 North America Epilepsy Drugs Market Size by Application (2017-2022)
    • 6.3.2 North America Epilepsy Drugs Market Size by Application (2023-2028)
    • 6.3.3 North America Epilepsy Drugs Market Share by Application (2017-2028)
  • 6.4 North America Epilepsy Drugs Market Size by Country
    • 6.4.1 North America Epilepsy Drugs Market Size by Country (2017-2022)
    • 6.4.2 North America Epilepsy Drugs Market Size by Country (2023-2028)
    • 6.4.3 U.S.
    • 6.4.4 Canada

7 Europe

  • 7.1 Europe Epilepsy Drugs Market Size (2017-2028)
  • 7.2 Europe Epilepsy Drugs Market Size by Type
    • 7.2.1 Europe Epilepsy Drugs Market Size by Type (2017-2022)
    • 7.2.2 Europe Epilepsy Drugs Market Size by Type (2023-2028)
    • 7.2.3 Europe Epilepsy Drugs Market Share by Type (2017-2028)
  • 7.3 Europe Epilepsy Drugs Market Size by Application
    • 7.3.1 Europe Epilepsy Drugs Market Size by Application (2017-2022)
    • 7.3.2 Europe Epilepsy Drugs Market Size by Application (2023-2028)
    • 7.3.3 Europe Epilepsy Drugs Market Share by Application (2017-2028)
  • 7.4 Europe Epilepsy Drugs Market Size by Country
    • 7.4.1 Europe Epilepsy Drugs Market Size by Country (2017-2022)
    • 7.4.2 Europe Epilepsy Drugs Market Size by Country (2023-2028)
    • 7.4.3 Germany
    • 7.4.4 France
    • 7.4.5 U.K.
    • 7.4.6 Italy
    • 7.4.7 Russia
    • 7.4.8 Nordic Countries

8 Asia-Pacific

  • 8.1 Asia-Pacific Epilepsy Drugs Market Size (2017-2028)
  • 8.2 Asia-Pacific Epilepsy Drugs Market Size by Type
    • 8.2.1 Asia-Pacific Epilepsy Drugs Market Size by Type (2017-2022)
    • 8.2.2 Asia-Pacific Epilepsy Drugs Market Size by Type (2023-2028)
    • 8.2.3 Asia-Pacific Epilepsy Drugs Market Share by Type (2017-2028)
  • 8.3 Asia-Pacific Epilepsy Drugs Market Size by Application
    • 8.3.1 Asia-Pacific Epilepsy Drugs Market Size by Application (2017-2022)
    • 8.3.2 Asia-Pacific Epilepsy Drugs Market Size by Application (2023-2028)
    • 8.3.3 Asia-Pacific Epilepsy Drugs Market Share by Application (2017-2028)
  • 8.4 Asia-Pacific Epilepsy Drugs Market Size by Region
    • 8.4.1 Asia-Pacific Epilepsy Drugs Market Size by Region (2017-2022)
    • 8.4.2 Asia-Pacific Epilepsy Drugs Market Size by Region (2023-2028)
    • 8.4.3 China
    • 8.4.4 Japan
    • 8.4.5 South Korea
    • 8.4.6 Southeast Asia
    • 8.4.7 India
    • 8.4.8 Australia

9 Latin America

  • 9.1 Latin America Epilepsy Drugs Market Size (2017-2028)
  • 9.2 Latin America Epilepsy Drugs Market Size by Type
    • 9.2.1 Latin America Epilepsy Drugs Market Size by Type (2017-2022)
    • 9.2.2 Latin America Epilepsy Drugs Market Size by Type (2023-2028)
    • 9.2.3 Latin America Epilepsy Drugs Market Share by Type (2017-2028)
  • 9.3 Latin America Epilepsy Drugs Market Size by Application
    • 9.3.1 Latin America Epilepsy Drugs Market Size by Application (2017-2022)
    • 9.3.2 Latin America Epilepsy Drugs Market Size by Application (2023-2028)
    • 9.3.3 Latin America Epilepsy Drugs Market Share by Application (2017-2028)
  • 9.4 Latin America Epilepsy Drugs Market Size by Country
    • 9.4.1 Latin America Epilepsy Drugs Market Size by Country (2017-2022)
    • 9.4.2 Latin America Epilepsy Drugs Market Size by Country (2023-2028)
    • 9.4.3 Mexico
    • 9.4.4 Brazil

10 Middle East & Africa

  • 10.1 Middle East & Africa Epilepsy Drugs Market Size (2017-2028)
  • 10.2 Middle East & Africa Epilepsy Drugs Market Size by Type
    • 10.2.1 Middle East & Africa Epilepsy Drugs Market Size by Type (2017-2022)
    • 10.2.2 Middle East & Africa Epilepsy Drugs Market Size by Type (2023-2028)
    • 10.2.3 Middle East & Africa Epilepsy Drugs Market Share by Type (2017-2028)
  • 10.3 Middle East & Africa Epilepsy Drugs Market Size by Application
    • 10.3.1 Middle East & Africa Epilepsy Drugs Market Size by Application (2017-2022)
    • 10.3.2 Middle East & Africa Epilepsy Drugs Market Size by Application (2023-2028)
    • 10.3.3 Middle East & Africa Epilepsy Drugs Market Share by Application (2017-2028)
  • 10.4 Middle East & Africa Epilepsy Drugs Market Size by Country
    • 10.4.1 Middle East & Africa Epilepsy Drugs Market Size by Country (2017-2022)
    • 10.4.2 Middle East & Africa Epilepsy Drugs Market Size by Country (2023-2028)
    • 10.4.3 Turkey
    • 10.4.4 Saudi Arabia
    • 10.4.5 UAE

11 Key Players Profiles

  • 11.1 Abbott Laboratories
    • 11.1.1 Abbott Laboratories Company Details
    • 11.1.2 Abbott Laboratories Business Overview
    • 11.1.3 Abbott Laboratories Epilepsy Drugs Introduction
    • 11.1.4 Abbott Laboratories Revenue in Epilepsy Drugs Business (2017-2022)
    • 11.1.5 Abbott Laboratories Recent Developments
  • 11.2 GlaxoSmithKline Plc
    • 11.2.1 GlaxoSmithKline Plc Company Details
    • 11.2.2 GlaxoSmithKline Plc Business Overview
    • 11.2.3 GlaxoSmithKline Plc Epilepsy Drugs Introduction
    • 11.2.4 GlaxoSmithKline Plc Revenue in Epilepsy Drugs Business (2017-2022)
    • 11.2.5 GlaxoSmithKline Plc Recent Developments
  • 11.3 UCB
    • 11.3.1 UCB Company Details
    • 11.3.2 UCB Business Overview
    • 11.3.3 UCB Epilepsy Drugs Introduction
    • 11.3.4 UCB Revenue in Epilepsy Drugs Business (2017-2022)
    • 11.3.5 UCB Recent Developments
  • 11.4 Cephalon
    • 11.4.1 Cephalon Company Details
    • 11.4.2 Cephalon Business Overview
    • 11.4.3 Cephalon Epilepsy Drugs Introduction
    • 11.4.4 Cephalon Revenue in Epilepsy Drugs Business (2017-2022)
    • 11.4.5 Cephalon Recent Developments
  • 11.5 Johnson & Johnson
    • 11.5.1 Johnson & Johnson Company Details
    • 11.5.2 Johnson & Johnson Business Overview
    • 11.5.3 Johnson & Johnson Epilepsy Drugs Introduction
    • 11.5.4 Johnson & Johnson Revenue in Epilepsy Drugs Business (2017-2022)
    • 11.5.5 Johnson & Johnson Recent Developments
  • 11.6 Pfizer
    • 11.6.1 Pfizer Company Details
    • 11.6.2 Pfizer Business Overview
    • 11.6.3 Pfizer Epilepsy Drugs Introduction
    • 11.6.4 Pfizer Revenue in Epilepsy Drugs Business (2017-2022)
    • 11.6.5 Pfizer Recent Developments
  • 11.7 Novartis AG
    • 11.7.1 Novartis AG Company Details
    • 11.7.2 Novartis AG Business Overview
    • 11.7.3 Novartis AG Epilepsy Drugs Introduction
    • 11.7.4 Novartis AG Revenue in Epilepsy Drugs Business (2017-2022)
    • 11.7.5 Novartis AG Recent Developments
  • 11.8 Abbvie
    • 11.8.1 Abbvie Company Details
    • 11.8.2 Abbvie Business Overview
    • 11.8.3 Abbvie Epilepsy Drugs Introduction
    • 11.8.4 Abbvie Revenue in Epilepsy Drugs Business (2017-2022)
    • 11.8.5 Abbvie Recent Developments
  • 11.9 Janssen Pharmaceuticals
    • 11.9.1 Janssen Pharmaceuticals Company Details
    • 11.9.2 Janssen Pharmaceuticals Business Overview
    • 11.9.3 Janssen Pharmaceuticals Epilepsy Drugs Introduction
    • 11.9.4 Janssen Pharmaceuticals Revenue in Epilepsy Drugs Business (2017-2022)
    • 11.9.5 Janssen Pharmaceuticals Recent Developments
  • 11.10 Sunovion Pharmaceuticals
    • 11.10.1 Sunovion Pharmaceuticals Company Details
    • 11.10.2 Sunovion Pharmaceuticals Business Overview
    • 11.10.3 Sunovion Pharmaceuticals Epilepsy Drugs Introduction
    • 11.10.4 Sunovion Pharmaceuticals Revenue in Epilepsy Drugs Business (2017-2022)
    • 11.10.5 Sunovion Pharmaceuticals Recent Developments
  • 11.11 Bausch Health
    • 11.11.1 Bausch Health Company Details
    • 11.11.2 Bausch Health Business Overview
    • 11.11.3 Bausch Health Epilepsy Drugs Introduction
    • 11.11.4 Bausch Health Revenue in Epilepsy Drugs Business (2017-2022)
    • 11.11.5 Bausch Health Recent Developments
  • 11.12 Sanofi S.A
    • 11.12.1 Sanofi S.A Company Details
    • 11.12.2 Sanofi S.A Business Overview
    • 11.12.3 Sanofi S.A Epilepsy Drugs Introduction
    • 11.12.4 Sanofi S.A Revenue in Epilepsy Drugs Business (2017-2022)
    • 11.12.5 Sanofi S.A Recent Developments
  • 11.13 Takeda
    • 11.13.1 Takeda Company Details
    • 11.13.2 Takeda Business Overview
    • 11.13.3 Takeda Epilepsy Drugs Introduction
    • 11.13.4 Takeda Revenue in Epilepsy Drugs Business (2017-2022)
    • 11.13.5 Takeda Recent Developments
  • 11.14 Eisai
    • 11.14.1 Eisai Company Details
    • 11.14.2 Eisai Business Overview
    • 11.14.3 Eisai Epilepsy Drugs Introduction
    • 11.14.4 Eisai Revenue in Epilepsy Drugs Business (2017-2022)
    • 11.14.5 Eisai Recent Developments
  • 11.15 F. Hoffmann-La Roche
    • 11.15.1 F. Hoffmann-La Roche Company Details
    • 11.15.2 F. Hoffmann-La Roche Business Overview
    • 11.15.3 F. Hoffmann-La Roche Epilepsy Drugs Introduction
    • 11.15.4 F. Hoffmann-La Roche Revenue in Epilepsy Drugs Business (2017-2022)
    • 11.15.5 F. Hoffmann-La Roche Recent Developments

12 Analyst's Viewpoints/Conclusions

13 Appendix

  • 13.1 Research Methodology
    • 13.1.1 Methodology/Research Approach
    • 13.1.2 Data Source
  • 13.2 Author Details
  • 13.3 Disclaimer

TABLE OF CONTENTS

1 Report Business Overview

  • 1.1 Study Scope
  • 1.2 Market Analysis by Type
    • 1.2.1 Global Epilepsy Drugs Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
    • 1.2.2 First Generation
    • 1.2.3 Second Generation
  • 1.3 Market by Application
    • 1.3.1 Global Epilepsy Drugs Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
    • 1.3.2 Hospital Pharmacies
    • 1.3.3 Retail Pharmacies
    • 1.3.4 Online Pharmacies
  • 1.4 Study Objectives
  • 1.5 Years Considered

2 Global Growth Trends

  • 2.1 Global Epilepsy Drugs Market Perspective (2017-2028)
  • 2.2 Epilepsy Drugs Growth Trends by Region
    • 2.2.1 Epilepsy Drugs Market Size by Region: 2017 VS 2021 VS 2028
    • 2.2.2 Epilepsy Drugs Historic Market Size by Region (2017-2022)
    • 2.2.3 Epilepsy Drugs Forecasted Market Size by Region (2023-2028)
  • 2.3 Epilepsy Drugs Market Dynamics
    • 2.3.1 Epilepsy Drugs Industry Trends
    • 2.3.2 Epilepsy Drugs Market Drivers
    • 2.3.3 Epilepsy Drugs Market Challenges
    • 2.3.4 Epilepsy Drugs Market Restraints

3 Competition Landscape by Key Players

  • 3.1 Global Top Epilepsy Drugs Players by Revenue
    • 3.1.1 Global Top Epilepsy Drugs Players by Revenue (2017-2022)
    • 3.1.2 Global Epilepsy Drugs Revenue Market Share by Players (2017-2022)
  • 3.2 Global Epilepsy Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
  • 3.3 Players Covered: Ranking by Epilepsy Drugs Revenue
  • 3.4 Global Epilepsy Drugs Market Concentration Ratio
    • 3.4.1 Global Epilepsy Drugs Market Concentration Ratio (CR5 and HHI)
    • 3.4.2 Global Top 10 and Top 5 Companies by Epilepsy Drugs Revenue in 2021
  • 3.5 Epilepsy Drugs Key Players Head office and Area Served
  • 3.6 Key Players Epilepsy Drugs Product Solution and Service
  • 3.7 Date of Enter into Epilepsy Drugs Market
  • 3.8 Mergers & Acquisitions, Expansion Plans

4 Epilepsy Drugs Breakdown Data by Type

  • 4.1 Global Epilepsy Drugs Historic Market Size by Type (2017-2022)
  • 4.2 Global Epilepsy Drugs Forecasted Market Size by Type (2023-2028)

5 Epilepsy Drugs Breakdown Data by Application

  • 5.1 Global Epilepsy Drugs Historic Market Size by Application (2017-2022)
  • 5.2 Global Epilepsy Drugs Forecasted Market Size by Application (2023-2028)

6 North America

  • 6.1 North America Epilepsy Drugs Market Size (2017-2028)
  • 6.2 North America Epilepsy Drugs Market Size by Type
    • 6.2.1 North America Epilepsy Drugs Market Size by Type (2017-2022)
    • 6.2.2 North America Epilepsy Drugs Market Size by Type (2023-2028)
    • 6.2.3 North America Epilepsy Drugs Market Share by Type (2017-2028)
  • 6.3 North America Epilepsy Drugs Market Size by Application
    • 6.3.1 North America Epilepsy Drugs Market Size by Application (2017-2022)
    • 6.3.2 North America Epilepsy Drugs Market Size by Application (2023-2028)
    • 6.3.3 North America Epilepsy Drugs Market Share by Application (2017-2028)
  • 6.4 North America Epilepsy Drugs Market Size by Country
    • 6.4.1 North America Epilepsy Drugs Market Size by Country (2017-2022)
    • 6.4.2 North America Epilepsy Drugs Market Size by Country (2023-2028)
    • 6.4.3 U.S.
    • 6.4.4 Canada

7 Europe

  • 7.1 Europe Epilepsy Drugs Market Size (2017-2028)
  • 7.2 Europe Epilepsy Drugs Market Size by Type
    • 7.2.1 Europe Epilepsy Drugs Market Size by Type (2017-2022)
    • 7.2.2 Europe Epilepsy Drugs Market Size by Type (2023-2028)
    • 7.2.3 Europe Epilepsy Drugs Market Share by Type (2017-2028)
  • 7.3 Europe Epilepsy Drugs Market Size by Application
    • 7.3.1 Europe Epilepsy Drugs Market Size by Application (2017-2022)
    • 7.3.2 Europe Epilepsy Drugs Market Size by Application (2023-2028)
    • 7.3.3 Europe Epilepsy Drugs Market Share by Application (2017-2028)
  • 7.4 Europe Epilepsy Drugs Market Size by Country
    • 7.4.1 Europe Epilepsy Drugs Market Size by Country (2017-2022)
    • 7.4.2 Europe Epilepsy Drugs Market Size by Country (2023-2028)
    • 7.4.3 Germany
    • 7.4.4 France
    • 7.4.5 U.K.
    • 7.4.6 Italy
    • 7.4.7 Russia
    • 7.4.8 Nordic Countries

8 Asia-Pacific

  • 8.1 Asia-Pacific Epilepsy Drugs Market Size (2017-2028)
  • 8.2 Asia-Pacific Epilepsy Drugs Market Size by Type
    • 8.2.1 Asia-Pacific Epilepsy Drugs Market Size by Type (2017-2022)
    • 8.2.2 Asia-Pacific Epilepsy Drugs Market Size by Type (2023-2028)
    • 8.2.3 Asia-Pacific Epilepsy Drugs Market Share by Type (2017-2028)
  • 8.3 Asia-Pacific Epilepsy Drugs Market Size by Application
    • 8.3.1 Asia-Pacific Epilepsy Drugs Market Size by Application (2017-2022)
    • 8.3.2 Asia-Pacific Epilepsy Drugs Market Size by Application (2023-2028)
    • 8.3.3 Asia-Pacific Epilepsy Drugs Market Share by Application (2017-2028)
  • 8.4 Asia-Pacific Epilepsy Drugs Market Size by Region
    • 8.4.1 Asia-Pacific Epilepsy Drugs Market Size by Region (2017-2022)
    • 8.4.2 Asia-Pacific Epilepsy Drugs Market Size by Region (2023-2028)
    • 8.4.3 China
    • 8.4.4 Japan
    • 8.4.5 South Korea
    • 8.4.6 Southeast Asia
    • 8.4.7 India
    • 8.4.8 Australia

9 Latin America

  • 9.1 Latin America Epilepsy Drugs Market Size (2017-2028)
  • 9.2 Latin America Epilepsy Drugs Market Size by Type
    • 9.2.1 Latin America Epilepsy Drugs Market Size by Type (2017-2022)
    • 9.2.2 Latin America Epilepsy Drugs Market Size by Type (2023-2028)
    • 9.2.3 Latin America Epilepsy Drugs Market Share by Type (2017-2028)
  • 9.3 Latin America Epilepsy Drugs Market Size by Application
    • 9.3.1 Latin America Epilepsy Drugs Market Size by Application (2017-2022)
    • 9.3.2 Latin America Epilepsy Drugs Market Size by Application (2023-2028)
    • 9.3.3 Latin America Epilepsy Drugs Market Share by Application (2017-2028)
  • 9.4 Latin America Epilepsy Drugs Market Size by Country
    • 9.4.1 Latin America Epilepsy Drugs Market Size by Country (2017-2022)
    • 9.4.2 Latin America Epilepsy Drugs Market Size by Country (2023-2028)
    • 9.4.3 Mexico
    • 9.4.4 Brazil

10 Middle East & Africa

  • 10.1 Middle East & Africa Epilepsy Drugs Market Size (2017-2028)
  • 10.2 Middle East & Africa Epilepsy Drugs Market Size by Type
    • 10.2.1 Middle East & Africa Epilepsy Drugs Market Size by Type (2017-2022)
    • 10.2.2 Middle East & Africa Epilepsy Drugs Market Size by Type (2023-2028)
    • 10.2.3 Middle East & Africa Epilepsy Drugs Market Share by Type (2017-2028)
  • 10.3 Middle East & Africa Epilepsy Drugs Market Size by Application
    • 10.3.1 Middle East & Africa Epilepsy Drugs Market Size by Application (2017-2022)
    • 10.3.2 Middle East & Africa Epilepsy Drugs Market Size by Application (2023-2028)
    • 10.3.3 Middle East & Africa Epilepsy Drugs Market Share by Application (2017-2028)
  • 10.4 Middle East & Africa Epilepsy Drugs Market Size by Country
    • 10.4.1 Middle East & Africa Epilepsy Drugs Market Size by Country (2017-2022)
    • 10.4.2 Middle East & Africa Epilepsy Drugs Market Size by Country (2023-2028)
    • 10.4.3 Turkey
    • 10.4.4 Saudi Arabia
    • 10.4.5 UAE

11 Key Players Profiles

  • 11.1 Abbott Laboratories
    • 11.1.1 Abbott Laboratories Company Details
    • 11.1.2 Abbott Laboratories Business Overview
    • 11.1.3 Abbott Laboratories Epilepsy Drugs Introduction
    • 11.1.4 Abbott Laboratories Revenue in Epilepsy Drugs Business (2017-2022)
    • 11.1.5 Abbott Laboratories Recent Developments
  • 11.2 GlaxoSmithKline Plc
    • 11.2.1 GlaxoSmithKline Plc Company Details
    • 11.2.2 GlaxoSmithKline Plc Business Overview
    • 11.2.3 GlaxoSmithKline Plc Epilepsy Drugs Introduction
    • 11.2.4 GlaxoSmithKline Plc Revenue in Epilepsy Drugs Business (2017-2022)
    • 11.2.5 GlaxoSmithKline Plc Recent Developments
  • 11.3 UCB
    • 11.3.1 UCB Company Details
    • 11.3.2 UCB Business Overview
    • 11.3.3 UCB Epilepsy Drugs Introduction
    • 11.3.4 UCB Revenue in Epilepsy Drugs Business (2017-2022)
    • 11.3.5 UCB Recent Developments
  • 11.4 Cephalon
    • 11.4.1 Cephalon Company Details
    • 11.4.2 Cephalon Business Overview
    • 11.4.3 Cephalon Epilepsy Drugs Introduction
    • 11.4.4 Cephalon Revenue in Epilepsy Drugs Business (2017-2022)
    • 11.4.5 Cephalon Recent Developments
  • 11.5 Johnson & Johnson
    • 11.5.1 Johnson & Johnson Company Details
    • 11.5.2 Johnson & Johnson Business Overview
    • 11.5.3 Johnson & Johnson Epilepsy Drugs Introduction
    • 11.5.4 Johnson & Johnson Revenue in Epilepsy Drugs Business (2017-2022)
    • 11.5.5 Johnson & Johnson Recent Developments
  • 11.6 Pfizer
    • 11.6.1 Pfizer Company Details
    • 11.6.2 Pfizer Business Overview
    • 11.6.3 Pfizer Epilepsy Drugs Introduction
    • 11.6.4 Pfizer Revenue in Epilepsy Drugs Business (2017-2022)
    • 11.6.5 Pfizer Recent Developments
  • 11.7 Novartis AG
    • 11.7.1 Novartis AG Company Details
    • 11.7.2 Novartis AG Business Overview
    • 11.7.3 Novartis AG Epilepsy Drugs Introduction
    • 11.7.4 Novartis AG Revenue in Epilepsy Drugs Business (2017-2022)
    • 11.7.5 Novartis AG Recent Developments
  • 11.8 Abbvie
    • 11.8.1 Abbvie Company Details
    • 11.8.2 Abbvie Business Overview
    • 11.8.3 Abbvie Epilepsy Drugs Introduction
    • 11.8.4 Abbvie Revenue in Epilepsy Drugs Business (2017-2022)
    • 11.8.5 Abbvie Recent Developments
  • 11.9 Janssen Pharmaceuticals
    • 11.9.1 Janssen Pharmaceuticals Company Details
    • 11.9.2 Janssen Pharmaceuticals Business Overview
    • 11.9.3 Janssen Pharmaceuticals Epilepsy Drugs Introduction
    • 11.9.4 Janssen Pharmaceuticals Revenue in Epilepsy Drugs Business (2017-2022)
    • 11.9.5 Janssen Pharmaceuticals Recent Developments
  • 11.10 Sunovion Pharmaceuticals
    • 11.10.1 Sunovion Pharmaceuticals Company Details
    • 11.10.2 Sunovion Pharmaceuticals Business Overview
    • 11.10.3 Sunovion Pharmaceuticals Epilepsy Drugs Introduction
    • 11.10.4 Sunovion Pharmaceuticals Revenue in Epilepsy Drugs Business (2017-2022)
    • 11.10.5 Sunovion Pharmaceuticals Recent Developments
  • 11.11 Bausch Health
    • 11.11.1 Bausch Health Company Details
    • 11.11.2 Bausch Health Business Overview
    • 11.11.3 Bausch Health Epilepsy Drugs Introduction
    • 11.11.4 Bausch Health Revenue in Epilepsy Drugs Business (2017-2022)
    • 11.11.5 Bausch Health Recent Developments
  • 11.12 Sanofi S.A
    • 11.12.1 Sanofi S.A Company Details
    • 11.12.2 Sanofi S.A Business Overview
    • 11.12.3 Sanofi S.A Epilepsy Drugs Introduction
    • 11.12.4 Sanofi S.A Revenue in Epilepsy Drugs Business (2017-2022)
    • 11.12.5 Sanofi S.A Recent Developments
  • 11.13 Takeda
    • 11.13.1 Takeda Company Details
    • 11.13.2 Takeda Business Overview
    • 11.13.3 Takeda Epilepsy Drugs Introduction
    • 11.13.4 Takeda Revenue in Epilepsy Drugs Business (2017-2022)
    • 11.13.5 Takeda Recent Developments
  • 11.14 Eisai
    • 11.14.1 Eisai Company Details
    • 11.14.2 Eisai Business Overview
    • 11.14.3 Eisai Epilepsy Drugs Introduction
    • 11.14.4 Eisai Revenue in Epilepsy Drugs Business (2017-2022)
    • 11.14.5 Eisai Recent Developments
  • 11.15 F. Hoffmann-La Roche
    • 11.15.1 F. Hoffmann-La Roche Company Details
    • 11.15.2 F. Hoffmann-La Roche Business Overview
    • 11.15.3 F. Hoffmann-La Roche Epilepsy Drugs Introduction
    • 11.15.4 F. Hoffmann-La Roche Revenue in Epilepsy Drugs Business (2017-2022)
    • 11.15.5 F. Hoffmann-La Roche Recent Developments

12 Analyst's Viewpoints/Conclusions

13 Appendix

  • 13.1 Research Methodology
    • 13.1.1 Methodology/Research Approach
    • 13.1.2 Data Source
  • 13.2 Author Details
  • 13.3 Disclaimer
  • Table 1. Global Epilepsy Drugs Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
  • Table 2. Key Players of First Generation
  • Table 3. Key Players of Second Generation
  • Table 4. Global Epilepsy Drugs Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
  • Table 5. Global Epilepsy Drugs Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
  • Table 6. Global Epilepsy Drugs Market Size by Region (2017-2022) & (US$ Million)
  • Table 7. Global Epilepsy Drugs Market Share by Region (2017-2022)
  • Table 8. Global Epilepsy Drugs Forecasted Market Size by Region (2023-2028) & (US$ Million)
  • Table 9. Global Epilepsy Drugs Market Share by Region (2023-2028)
  • Table 10. Epilepsy Drugs Market Trends
  • Table 11. Epilepsy Drugs Market Drivers
  • Table 12. Epilepsy Drugs Market Challenges
  • Table 13. Epilepsy Drugs Market Restraints
  • Table 14. Global Epilepsy Drugs Revenue by Players (2017-2022) & (US$ Million)
  • Table 15. Global Epilepsy Drugs Revenue Share by Players (2017-2022)
  • Table 16. Global Top Epilepsy Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Epilepsy Drugs as of 2021)
  • Table 17. Ranking of Global Top Epilepsy Drugs Companies by Revenue (US$ Million) in 2021
  • Table 18. Global 5 Largest Players Market Share by Epilepsy Drugs Revenue (CR5 and HHI) & (2017-2022)
  • Table 19. Key Players Headquarters and Area Served
  • Table 20. Key Players Epilepsy Drugs Product Solution and Service
  • Table 21. Date of Enter into Epilepsy Drugs Market
  • Table 22. Mergers & Acquisitions, Expansion Plans
  • Table 23. Global Epilepsy Drugs Market Size by Type (2017-2022) & (US$ Million)
  • Table 24. Global Epilepsy Drugs Revenue Market Share by Type (2017-2022)
  • Table 25. Global Epilepsy Drugs Forecasted Market Size by Type (2023-2028) & (US$ Million)
  • Table 26. Global Epilepsy Drugs Revenue Market Share by Type (2023-2028)
  • Table 27. Global Epilepsy Drugs Market Size by Application (2017-2022) & (US$ Million)
  • Table 28. Global Epilepsy Drugs Revenue Share by Application (2017-2022)
  • Table 29. Global Epilepsy Drugs Forecasted Market Size by Application (2023-2028) & (US$ Million)
  • Table 30. Global Epilepsy Drugs Revenue Share by Application (2023-2028)
  • Table 31. North America Epilepsy Drugs Market Size by Type (2017-2022) & (US$ Million)
  • Table 32. North America Epilepsy Drugs Market Size by Type (2023-2028) & (US$ Million)
  • Table 33. North America Epilepsy Drugs Market Size by Application (2017-2022) & (US$ Million)
  • Table 34. North America Epilepsy Drugs Market Size by Application (2023-2028) & (US$ Million)
  • Table 35. North America Epilepsy Drugs Market Size by Country (2017-2022) & (US$ Million)
  • Table 36. North America Epilepsy Drugs Market Size by Country (2023-2028) & (US$ Million)
  • Table 37. Europe Epilepsy Drugs Market Size by Type (2017-2022) & (US$ Million)
  • Table 38. Europe Epilepsy Drugs Market Size by Type (2023-2028) & (US$ Million)
  • Table 39. Europe Epilepsy Drugs Market Size by Application (2017-2022) & (US$ Million)
  • Table 40. Europe Epilepsy Drugs Market Size by Application (2023-2028) & (US$ Million)
  • Table 41. Europe Epilepsy Drugs Market Size by Country (2017-2022) & (US$ Million)
  • Table 42. Europe Epilepsy Drugs Market Size by Country (2023-2028) & (US$ Million)
  • Table 43. Asia Pacific Epilepsy Drugs Market Size by Type (2017-2022) & (US$ Million)
  • Table 44. Asia Pacific Epilepsy Drugs Market Size by Type (2023-2028) & (US$ Million)
  • Table 45. Asia Pacific Epilepsy Drugs Market Size by Application (2017-2022) & (US$ Million)
  • Table 46. Asia Pacific Epilepsy Drugs Market Size by Application (2023-2028) & (US$ Million)
  • Table 47. Asia Pacific Epilepsy Drugs Market Size by Region (2017-2022) & (US$ Million)
  • Table 48. Asia Pacific Epilepsy Drugs Market Size by Region (2023-2028) & (US$ Million)
  • Table 49. Latin America Epilepsy Drugs Market Size by Type (2017-2022) & (US$ Million)
  • Table 50. Latin America Epilepsy Drugs Market Size by Type (2023-2028) & (US$ Million)
  • Table 51. Latin America Epilepsy Drugs Market Size by Application (2017-2022) & (US$ Million)
  • Table 52. Latin America Epilepsy Drugs Market Size by Application (2023-2028) & (US$ Million)
  • Table 53. Latin America Epilepsy Drugs Market Size by Country (2017-2022) & (US$ Million)
  • Table 54. Latin America Epilepsy Drugs Market Size by Country (2023-2028) & (US$ Million)
  • Table 55. Middle East and Africa Epilepsy Drugs Market Size by Type (2017-2022) & (US$ Million)
  • Table 56. Middle East and Africa Epilepsy Drugs Market Size by Type (2023-2028) & (US$ Million)
  • Table 57. Middle East and Africa Epilepsy Drugs Market Size by Application (2017-2022) & (US$ Million)
  • Table 58. Middle East and Africa Epilepsy Drugs Market Size by Application (2023-2028) & (US$ Million)
  • Table 59. Middle East and Africa Epilepsy Drugs Market Size by Country (2017-2022) & (US$ Million)
  • Table 60. Middle East and Africa Epilepsy Drugs Market Size by Country (2023-2028) & (US$ Million)
  • Table 61. Abbott Laboratories Company Details
  • Table 62. Abbott Laboratories Business Overview
  • Table 63. Abbott Laboratories Epilepsy Drugs Product
  • Table 64. Abbott Laboratories Revenue in Epilepsy Drugs Business (2017-2022) & (US$ Million)
  • Table 65. Abbott Laboratories Recent Developments
  • Table 66. GlaxoSmithKline Plc Company Details
  • Table 67. GlaxoSmithKline Plc Business Overview
  • Table 68. GlaxoSmithKline Plc Epilepsy Drugs Product
  • Table 69. GlaxoSmithKline Plc Revenue in Epilepsy Drugs Business (2017-2022) & (US$ Million)
  • Table 70. GlaxoSmithKline Plc Recent Developments
  • Table 71. UCB Company Details
  • Table 72. UCB Business Overview
  • Table 73. UCB Epilepsy Drugs Product
  • Table 74. UCB Revenue in Epilepsy Drugs Business (2017-2022) & (US$ Million)
  • Table 75. UCB Recent Developments
  • Table 76. Cephalon Company Details
  • Table 77. Cephalon Business Overview
  • Table 78. Cephalon Epilepsy Drugs Product
  • Table 79. Cephalon Revenue in Epilepsy Drugs Business (2017-2022) & (US$ Million)
  • Table 80. Cephalon Recent Developments
  • Table 81. Johnson & Johnson Company Details
  • Table 82. Johnson & Johnson Business Overview
  • Table 83. Johnson & Johnson Epilepsy Drugs Product
  • Table 84. Johnson & Johnson Revenue in Epilepsy Drugs Business (2017-2022) & (US$ Million)
  • Table 85. Johnson & Johnson Recent Developments
  • Table 86. Pfizer Company Details
  • Table 87. Pfizer Business Overview
  • Table 88. Pfizer Epilepsy Drugs Product
  • Table 89. Pfizer Revenue in Epilepsy Drugs Business (2017-2022) & (US$ Million)
  • Table 90. Pfizer Recent Developments
  • Table 91. Novartis AG Company Details
  • Table 92. Novartis AG Business Overview
  • Table 93. Novartis AG Epilepsy Drugs Product
  • Table 94. Novartis AG Revenue in Epilepsy Drugs Business (2017-2022) & (US$ Million)
  • Table 95. Novartis AG Recent Developments
  • Table 96. Abbvie Company Details
  • Table 97. Abbvie Business Overview
  • Table 98. Abbvie Epilepsy Drugs Product
  • Table 99. Abbvie Revenue in Epilepsy Drugs Business (2017-2022) & (US$ Million)
  • Table 100. Abbvie Recent Developments
  • Table 101. Janssen Pharmaceuticals Company Details
  • Table 102. Janssen Pharmaceuticals Business Overview
  • Table 103. Janssen Pharmaceuticals Epilepsy Drugs Product
  • Table 104. Janssen Pharmaceuticals Revenue in Epilepsy Drugs Business (2017-2022) & (US$ Million)
  • Table 105. Janssen Pharmaceuticals Recent Developments
  • Table 106. Sunovion Pharmaceuticals Company Details
  • Table 107. Sunovion Pharmaceuticals Business Overview
  • Table 108. Sunovion Pharmaceuticals Epilepsy Drugs Product
  • Table 109. Sunovion Pharmaceuticals Revenue in Epilepsy Drugs Business (2017-2022) & (US$ Million)
  • Table 110. Sunovion Pharmaceuticals Recent Developments
  • Table 111. Bausch Health Company Details
  • Table 112. Bausch Health Business Overview
  • Table 113. Bausch Health Epilepsy Drugs Product
  • Table 114. Bausch Health Revenue in Epilepsy Drugs Business (2017-2022) & (US$ Million)
  • Table 115. Bausch Health Recent Developments
  • Table 116. Sanofi S.A Company Details
  • Table 117. Sanofi S.A Business Overview
  • Table 118. Sanofi S.A Epilepsy Drugs Product
  • Table 119. Sanofi S.A Revenue in Epilepsy Drugs Business (2017-2022) & (US$ Million)
  • Table 120. Sanofi S.A Recent Developments
  • Table 121. Takeda Company Details
  • Table 122. Takeda Business Overview
  • Table 123. Takeda Epilepsy Drugs Product
  • Table 124. Takeda Revenue in Epilepsy Drugs Business (2017-2022) & (US$ Million)
  • Table 125. Takeda Recent Developments
  • Table 126. Eisai Company Details
  • Table 127. Eisai Business Overview
  • Table 128. Eisai Epilepsy Drugs Product
  • Table 129. Eisai Revenue in Epilepsy Drugs Business (2017-2022) & (US$ Million)
  • Table 130. Eisai Recent Developments
  • Table 131. F. Hoffmann-La Roche Company Details
  • Table 132. F. Hoffmann-La Roche Business Overview
  • Table 133. F. Hoffmann-La Roche Epilepsy Drugs Product
  • Table 134. F. Hoffmann-La Roche Revenue in Epilepsy Drugs Business (2017-2022) & (US$ Million)
  • Table 135. F. Hoffmann-La Roche Recent Developments
  • Table 136. Research Programs/Design for This Report
  • Table 137. Key Data Information from Secondary Sources
  • Table 138. Key Data Information from Primary Sources

List of Figures

  • Figure 1. Global Epilepsy Drugs Market Share by Type: 2021 VS 2028
  • Figure 2. First Generation Features
  • Figure 3. Second Generation Features
  • Figure 4. Global Epilepsy Drugs Market Share by Application: 2021 VS 2028
  • Figure 5. Hospital Pharmacies Case Studies
  • Figure 6. Retail Pharmacies Case Studies
  • Figure 7. Online Pharmacies Case Studies
  • Figure 8. Epilepsy Drugs Report Years Considered
  • Figure 9. Global Epilepsy Drugs Market Size (US$ Million), Year-over-Year: 2017-2028
  • Figure 10. Global Epilepsy Drugs Market Size, (US$ Million), 2017 VS 2021 VS 2028
  • Figure 11. Global Epilepsy Drugs Market Share by Region: 2021 VS 2028
  • Figure 12. Global Epilepsy Drugs Market Share by Players in 2021
  • Figure 13. Global Top Epilepsy Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Epilepsy Drugs as of 2021)
  • Figure 14. The Top 10 and 5 Players Market Share by Epilepsy Drugs Revenue in 2021
  • Figure 15. North America Epilepsy Drugs Market Size YoY (2017-2028) & (US$ Million)
  • Figure 16. North America Epilepsy Drugs Market Size Market Share by Type (2017-2028)
  • Figure 17. North America Epilepsy Drugs Market Size Market Share by Application (2017-2028)
  • Figure 18. North America Epilepsy Drugs Market Size Share by Country (2017-2028)
  • Figure 19. United States Epilepsy Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 20. Canada Epilepsy Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 21. Europe Epilepsy Drugs Market Size YoY (2017-2028) & (US$ Million)
  • Figure 22. Europe Epilepsy Drugs Market Size Market Share by Type (2017-2028)
  • Figure 23. Europe Epilepsy Drugs Market Size Market Share by Application (2017-2028)
  • Figure 24. Europe Epilepsy Drugs Market Size Share by Country (2017-2028)
  • Figure 25. Germany Epilepsy Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 26. France Epilepsy Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 27. U.K. Epilepsy Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 28. Italy Epilepsy Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 29. Russia Epilepsy Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 30. Nordic Countries Epilepsy Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 31. Asia-Pacific Epilepsy Drugs Market Size YoY (2017-2028) & (US$ Million)
  • Figure 32. Asia Pacific Epilepsy Drugs Market Size Market Share by Type (2017-2028)
  • Figure 33. Asia Pacific Epilepsy Drugs Market Size Market Share by Application (2017-2028)
  • Figure 34. Asia Pacific Epilepsy Drugs Market Size Share by Region (2017-2028)
  • Figure 35. China Epilepsy Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 36. Japan Epilepsy Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 37. South Korea Epilepsy Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 38. Southeast Asia Epilepsy Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 39. India Epilepsy Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 40. Australia Epilepsy Drugs Market Size YoY Growth (2017-2028) & (US$ Million)

List of Figures

  • Figure 41. Latin America Epilepsy Drugs Market Size YoY (2017-2028) & (US$ Million)
  • Figure 42. Latin America Epilepsy Drugs Market Size Market Share by Type (2017-2028)
  • Figure 43. Latin America Epilepsy Drugs Market Size Market Share by Application (2017-2028)
  • Figure 44. Latin America Epilepsy Drugs Market Size Share by Country (2017-2028)
  • Figure 45. Mexico Epilepsy Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 46. Brazil Epilepsy Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 47. Middle East & Africa Epilepsy Drugs Market Size YoY (2017-2028) & (US$ Million)
  • Figure 48. Middle East and Africa Epilepsy Drugs Market Size Market Share by Type (2017-2028)
  • Figure 49. Middle East and Africa Epilepsy Drugs Market Size Market Share by Application (2017-2028)
  • Figure 50. Middle East and Africa Epilepsy Drugs Market Size Share by Country (2017-2028)
  • Figure 51. Turkey Epilepsy Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 52. Saudi Arabia Epilepsy Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 53. UAE Epilepsy Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 54. Abbott Laboratories Revenue Growth Rate in Epilepsy Drugs Business (2017-2022)
  • Figure 55. GlaxoSmithKline Plc Revenue Growth Rate in Epilepsy Drugs Business (2017-2022)
  • Figure 56. UCB Revenue Growth Rate in Epilepsy Drugs Business (2017-2022)
  • Figure 57. Cephalon Revenue Growth Rate in Epilepsy Drugs Business (2017-2022)
  • Figure 58. Johnson & Johnson Revenue Growth Rate in Epilepsy Drugs Business (2017-2022)
  • Figure 59. Pfizer Revenue Growth Rate in Epilepsy Drugs Business (2017-2022)
  • Figure 60. Novartis AG Revenue Growth Rate in Epilepsy Drugs Business (2017-2022)
  • Figure 61. Abbvie Revenue Growth Rate in Epilepsy Drugs Business (2017-2022)
  • Figure 62. Janssen Pharmaceuticals Revenue Growth Rate in Epilepsy Drugs Business (2017-2022)
  • Figure 63. Sunovion Pharmaceuticals Revenue Growth Rate in Epilepsy Drugs Business (2017-2022)
  • Figure 64. Bausch Health Revenue Growth Rate in Epilepsy Drugs Business (2017-2022)
  • Figure 65. Sanofi S.A Revenue Growth Rate in Epilepsy Drugs Business (2017-2022)
  • Figure 66. Takeda Revenue Growth Rate in Epilepsy Drugs Business (2017-2022)
  • Figure 67. Eisai Revenue Growth Rate in Epilepsy Drugs Business (2017-2022)
  • Figure 68. F. Hoffmann-La Roche Revenue Growth Rate in Epilepsy Drugs Business (2017-2022)
  • Figure 69. Bottom-up and Top-down Approaches for This Report
  • Figure 70. Data Triangulation
  • Figure 71. Key Executives Interviewed
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!